中国中枢神经系统胶质瘤免疫和靶向治疗专家共识

2018-01-30 中国医师协会脑胶质瘤专业委员会 中华医学杂志.2018.98(5):324-331.

为规范和提高胶质瘤的免疫治疗和靶向治疗,中国医师协会脑胶质瘤专委会和上海抗癌协会神经肿瘤分会牵头,组织国内有关专家,经反复讨论和修改,首次制订了《中国中枢神经系统胶质瘤免疫及靶向治疗专家共识》(以下简称共识),供广大临床医务工作者参考和应用,希望能有助规范和推动我国胶质瘤的治疗,最终造福于广大患者及其家属。

中文标题:

中国中枢神经系统胶质瘤免疫和靶向治疗专家共识

发布日期:

2018-01-30

简要介绍:

为规范和提高胶质瘤的免疫治疗和靶向治疗,中国医师协会脑胶质瘤专委会和上海抗癌协会神经肿瘤分会牵头,组织国内有关专家,经反复讨论和修改,首次制订了《中国中枢神经系统胶质瘤免疫及靶向治疗专家共识》(以下简称共识),供广大临床医务工作者参考和应用,希望能有助规范和推动我国胶质瘤的治疗,最终造福于广大患者及其家属。

 

拓展指南:神经胶质瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国中枢神经系统胶质瘤免疫和靶向治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=558d41c0015a955a, title=中国中枢神经系统胶质瘤免疫和靶向治疗专家共识, enTitle=, guiderFrom=中华医学杂志.2018.98(5):324-331., authorId=null, author=, summary=为规范和提高胶质瘤的免疫治疗和靶向治疗,中国医师协会脑胶质瘤专委会和上海抗癌协会神经肿瘤分会牵头,组织国内有关专家,经反复讨论和修改,首次制订了《中国中枢神经系统胶质瘤免疫及靶向治疗专家共识》(以下简称共识),供广大临床医务工作者参考和应用,希望能有助规范和推动我国胶质瘤的治疗,最终造福于广大患者及其家属。 , cover=, journalId=null, articlesId=null, associationId=1589, associationName=中国医师协会脑胶质瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>为规范和提高胶质瘤的免疫治疗和靶向治疗,中国医师协会脑胶质瘤专委会和上海抗癌协会神经肿瘤分会牵头,组织国内有关专家,经反复讨论和修改,首次制订了《中国中枢神经系统胶质瘤免疫及靶向治疗专家共识》(以下简称共识),供广大临床医务工作者参考和应用,希望能有助规范和推动我国胶质瘤的治疗,最终造福于广大患者及其家属。</P> <P> </P>拓展指南:<STRONG>与<FONT color=red>神经胶质瘤</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2017 EANO指南:成人神经胶质瘤的姑息治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=653691c001a54654">2017 EANO指南:成人神经胶质瘤的姑息治疗</A> <LI><A title="2014 EANO指南:未分化神经胶质瘤和胶质母细胞瘤的诊断和治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=4ce7e1c0010991ba">2014 EANO指南:未分化神经胶质瘤和胶质母细胞瘤的诊断和治疗</A> <LI><A title="2014 ESMO临床实践指南:高级别神经胶质瘤的诊断,治疗和随访" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=bdd471c001068af1">2014 ESMO临床实践指南:高级别神经胶质瘤的诊断,治疗和随访</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E7%A5%9E%E7%BB%8F%E8%83%B6%E8%B4%A8%E7%98%A4">有关神经胶质瘤更多指南</A></LI></UL>, tagList=[TagDto(tagId=10519, tagName=中枢神经系统胶质瘤), TagDto(tagId=1246, tagName=免疫治疗), TagDto(tagId=721, tagName=靶向治疗)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7520, appHits=319, showAppHits=0, pcHits=5646, showPcHits=2577, likes=173, shares=22, comments=2, approvalStatus=1, publishedTime=Tue Jan 30 14:44:25 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 30 14:44:25 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 01:43:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国中枢神经系统胶质瘤免疫和靶向治疗专家共识)])
中国中枢神经系统胶质瘤免疫和靶向治疗专家共识
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=283548, encodeId=86b128354858, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Jan 30 16:18:06 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283533, encodeId=065b2835335c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Tue Jan 30 15:29:06 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2018-01-30 wqkm

    ^_^^_^^_^^_^

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=283548, encodeId=86b128354858, content=^_^^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Jan 30 16:18:06 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283533, encodeId=065b2835335c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Tue Jan 30 15:29:06 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2018-01-30 1e17414fm02(暂无匿称)

    学习

    0